Northern VA Compounders PLLC: Drug Recall
Recall #D-0108-2023 · 12/30/2022
Class II: Risk
Recall Details
- Recall Number
- D-0108-2023
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- Northern VA Compounders PLLC
- Status
- Terminated
- Date Initiated
- 12/30/2022
- Location
- Sterling, VA, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 6 vials
Reason for Recall
Lack of Assurance of Sterility
Product Description
QuadMix Super 002 (PGE1/Papaverine HCl/Phentolamine Mesylate/Atropine) 40mcg/30mg/4mg/0.4mg/mL INJECTABLE, packaged in 2.5 mL Multiple-Dose vials, Rx Only, Compounded by: Akina Pharmacy, 23475 Rock Haven Way Suite 105, Sterling, VA 20166.
Distribution Pattern
Nationwide in the USA
Other Recalls by Northern VA Compounders PLLC
- Class II: Risk 12/30/2022
- Class II: Risk 12/30/2022
- Class II: Risk 12/30/2022
- Class II: Risk 12/30/2022
- Class II: Risk 12/30/2022
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.